Exact Sciences
EXAS
#1767
Rank
โ‚ฌ8.88 B
Marketcap
48,00ย โ‚ฌ
Share price
-3.29%
Change (1 day)
-13.94%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -โ‚ฌ0.15 Billion

According to Exact Sciences's latest financial reports the company's current earnings are โ‚ฌ2.61 Billion. In 2023 the company made an earning of -โ‚ฌ0.18 Billion, an increase over its 2022 earnings that were of -โ‚ฌ0.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ0.15 Billion-17.62%
2023 -โ‚ฌ0.18 Billion-69.98%
2022 -โ‚ฌ0.58 Billion-25.55%
2021 -โ‚ฌ0.78 Billion1.68%
2020 -โ‚ฌ0.77 Billion271.17%
2019 -โ‚ฌ0.21 Billion58.99%
2018 -โ‚ฌ0.13 Billion20.89%
2017 -โ‚ฌ0.11 Billion-30.95%
2016 -โ‚ฌ0.16 Billion5.09%
2015 -โ‚ฌ0.15 Billion57.24%
2014 -โ‚ฌ93.47 Million116.53%
2013 -โ‚ฌ43.17 Million
2011 -โ‚ฌ26.88 Million143.73%
2010 -โ‚ฌ11.03 Million27.85%
2009 -โ‚ฌ8.63 Million0.27%
2008 -โ‚ฌ8.61 Million-20.95%
2007 -โ‚ฌ10.89 Million-13.53%
2006 -โ‚ฌ12.59 Million-10.07%
2005 -โ‚ฌ14 Million-21.81%
2004 -โ‚ฌ17.9 Million-33.44%
2003 -โ‚ฌ26.89 Million-6.51%
2002 -โ‚ฌ28.76 Million17.95%
2001 -โ‚ฌ24.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.15 Billion-0.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ61.42 M-142.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ51.09 Million-64.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ32.61 Million-77.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.90 B-4,883.42%๐Ÿ‡ซ๐Ÿ‡ท France